rs552351247

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong

The NM_001159542.3(POU5F1B):​c.304G>A​(p.Gly102Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000533 in 1,613,790 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00030 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000027 ( 0 hom. )

Consequence

POU5F1B
NM_001159542.3 missense

Scores

1
18

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -1.31

Publications

1 publications found
Variant links:
Genes affected
POU5F1B (HGNC:9223): (POU class 5 homeobox 1B) This intronless gene was thought to be a transcribed pseudogene of POU class 5 homeobox 1, however, it has been reported that this gene can encode a functional protein. The encoded protein is nearly the same length as and highly similar to the POU class 5 homeobox 1 transcription factor, has been shown to be a weak transcriptional activator and may play a role in carcinogenesis and eye development. [provided by RefSeq, Apr 2009]
CASC8 (HGNC:45129): (cancer susceptibility 8)
PCAT1 (HGNC:43022): (prostate cancer associated transcript 1) This gene produces a long non-coding RNA that promotes cell proliferation and is upregulated in prostate, colorectal, and other cancers. This RNA negatively regulates the BRCA2 tumor suppressor protein and positively regulates Myc oncoprotein. It contains binding sites for microRNAs, and may act as a sponge for microRNAs that regulate cell growth pathways. [provided by RefSeq, Dec 2017]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.02239129).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
POU5F1BNM_001159542.3 linkc.304G>A p.Gly102Arg missense_variant Exon 1 of 1 ENST00000696633.1 NP_001153014.1 Q06416
POU5F1BNM_001395745.1 linkc.304G>A p.Gly102Arg missense_variant Exon 2 of 2 NP_001382674.1
CASC8NR_117100.1 linkn.1176+4659C>T intron_variant Intron 5 of 5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
POU5F1BENST00000696633.1 linkc.304G>A p.Gly102Arg missense_variant Exon 1 of 1 NM_001159542.3 ENSP00000512769.1 Q06416

Frequencies

GnomAD3 genomes
AF:
0.000276
AC:
42
AN:
152194
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000892
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000262
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.0000685
AC:
17
AN:
248102
AF XY:
0.0000371
show subpopulations
Gnomad AFR exome
AF:
0.000784
Gnomad AMR exome
AF:
0.000145
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000274
AC:
40
AN:
1461478
Hom.:
0
Cov.:
113
AF XY:
0.0000248
AC XY:
18
AN XY:
727046
show subpopulations
African (AFR)
AF:
0.000837
AC:
28
AN:
33470
American (AMR)
AF:
0.000112
AC:
5
AN:
44710
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26130
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39696
South Asian (SAS)
AF:
0.0000232
AC:
2
AN:
86228
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53388
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5694
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1111804
Other (OTH)
AF:
0.0000828
AC:
5
AN:
60358
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
3
6
8
11
14
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000302
AC:
46
AN:
152312
Hom.:
0
Cov.:
33
AF XY:
0.000188
AC XY:
14
AN XY:
74466
show subpopulations
African (AFR)
AF:
0.000986
AC:
41
AN:
41580
American (AMR)
AF:
0.000261
AC:
4
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68006
Other (OTH)
AF:
0.000473
AC:
1
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
3
5
8
10
13
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000203
Hom.:
0
Bravo
AF:
0.000329
ExAC
AF:
0.0000660
AC:
8
Asia WGS
AF:
0.000866
AC:
3
AN:
3478

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Apr 25, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.304G>A (p.G102R) alteration is located in exon 1 (coding exon 1) of the POU5F1B gene. This alteration results from a G to A substitution at nucleotide position 304, causing the glycine (G) at amino acid position 102 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.093
BayesDel_addAF
Benign
-0.49
T
BayesDel_noAF
Benign
-0.56
CADD
Benign
0.15
DANN
Benign
0.84
DEOGEN2
Benign
0.0049
T;T
Eigen
Benign
-1.9
Eigen_PC
Benign
-1.9
FATHMM_MKL
Benign
0.0030
N
LIST_S2
Benign
0.62
.;T
M_CAP
Benign
0.0099
T
MetaRNN
Benign
0.022
T;T
MetaSVM
Benign
-0.96
T
MutationAssessor
Benign
0.83
L;L
PhyloP100
-1.3
PrimateAI
Uncertain
0.53
T
PROVEAN
Benign
-0.51
.;N
REVEL
Benign
0.15
Sift
Benign
1.0
.;T
Sift4G
Benign
0.48
.;T
Polyphen
0.0030
B;B
Vest4
0.042
MutPred
0.24
Gain of methylation at G102 (P = 0.0211);Gain of methylation at G102 (P = 0.0211);
MVP
0.11
MPC
0.045
ClinPred
0.011
T
GERP RS
-2.1
Varity_R
0.044
gMVP
0.26
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs552351247; hg19: chr8-128428415; API